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Available online 23 October 2007Glutamate receptors of the α-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid (AMPA)-type play an important role in synaptic
plasticity and contribute to cell death under excitotoxic conditions.
AMPA receptors form heterotetramers of four homologous subunits
(GluR1–4), which exist in two functionally different isoforms, flip and
flop, generated by alternative splicing. We identified transcripts for
alternatively spliced isoforms of AMPA receptor subunits which lack
both the flip and the flop exons, in hippocampal and retinal cultures.
These transcripts originate AMPA receptor subunits lacking the flip/
flop cassette, the fourth transmembrane domain and the intracellular
C-terminus. Truncated GluR1 associates with full-length GluR1 and
exerts a dominant negative effect, giving rise to non-functional
receptors. Moreover, truncated GluR1 reaches the cell surface, but is
not efficiently targeted to the synapse. Hippocampal neuronal
transfection with truncated GluR1 resulted in a significant reduction
in apoptotic neuronal death triggered by toxic concentrations of
glutamate. Furthermore, mRNA coding for the truncated subunits is
consistently detected in some regions of the brain in epileptic rats and
in hippocampal neurons submitted to toxic concentrations of gluta-
mate. The existence of truncated AMPA receptor subunits may
constitute an intrinsic neuroprotective mechanism.
© 2007 Published by Elsevier Inc.
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doi:10.1016/j.mcn.2007.10.008isoxazolepropionic acid (AMPA)-type glutamate receptors. These
receptors are also implicated in specific forms of synaptic
plasticity, such as long-term potentiation (LTP) and long-term
depression (LTD) (Malenka and Bear, 2004), and in excitotoxicity
(Kwak and Weiss, 2006).
AMPA receptors are heterotetramers of subunits GluR1–4
(Hollmann and Heinemann, 1994). mRNA coding for AMPA
receptors is translated in the rough endoplasmic reticulum (RER),
where receptor assembly begins (Bredt and Nicoll, 2003). The
first step in assembly of AMPA receptors is the formation of
dimers, through the N-terminal region of receptor subunits,
followed by the dimerization of dimers into tetramers (Ayalon
and Stern-Bach, 2001). AMPA receptors transit through the Golgi,
where they are glycosylated into mature receptors (Bredt and
Nicoll, 2003), they are subsequently targeted to the plasma
membrane in a dynamically regulated manner (Gomes et al.,
2003), and are specifically clustered at excitatory synapses on
dendritic spines and shafts. Given that the translation of mRNA
that encodes these subunits is believed to occur largely in the cell
soma, the synaptic targeting of the receptors requires directed
protein transport and synaptic stabilization (O'Brien et al., 1998).
AMPA receptor trafficking is regulated by numerous AMPA
receptor-binding proteins, depending on their subunit composi-
tion. It is widely accepted that the trafficking of AMPA-type
receptors in an activity-dependent manner mediates rapid synaptic
modification underlying LTP and LTD (Malinow and Malenka,
2002).
AMPA receptor subunit composition determines channel
function (Ozawa et al., 1998) and trafficking to synapses (Malinow
et al., 2000). All subunits have a similar domain structure, com-
posed of a large extracellular N-terminus followed by four mem-
brane domains (M1–M4), the second of which (M2) loops in and
out of the intracellular side of the membrane and forms a cation
permeable channel (Ozawa et al., 1998; Madden, 2002). The third
membrane domain leads to an extracellular loop that, together with
part of the amino-terminal domain (NTD), forms the glutamate
binding site (S1S2) (Hollmann et al., 1994). After the fourth
transmembrane domain, AMPA receptors end in an intracellular
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ho et al., 2000) and multiple sites of interaction with intracellular
proteins, such as PDZ domain-containing proteins of the post-
synaptic density (Gomes et al., 2003). The four subunits of AMPA
receptors exist in two distinct forms, flip and flop, generated by
alternative splicing of the 115 base pair (bp) exons that constitute the
flip/flop cassette (Sommer et al., 1990) and encode part of the
extracellular segment that precedes the fourth transmembrane
domain. This region is not involved directly in ligand binding but
appears to modulate receptor desensitization and channel conduc-
tance (Mosbacher et al., 1994). Flop versions are more abundant in
adult neurons than in the developing brain and usually desensitize
more rapidly than flip versions (Monyer et al., 1991).
Alternative splicing is of major importance in generating
proteomic diversity and in modulating protein activities in a
temporal and spatial manner (Grabowski and Black, 2001).
Approximately 40% to 60% of human genes are alternatively
spliced (Modrek and Lee, 2002). In the brain, the expression profiles
of splice isoforms are modified during development and as neuronal
activity changes (Lipscombe, 2005). For N-methyl-D-aspartic acid
(NMDA) receptors, a direct link between NR1 mRNA splicing,
activity and synaptic homeostasis was established (Mu et al., 2003).
Chronic activity blockade increases the expression of the splicing
variants of NR1 with accelerated endoplasmic reticulum (ER)
export, whereas the expression of other splice variants decreases.
Conversely, increasing neuronal activity caused an inverse change in
the expression of NR1 splice variants.
In this study, we identified an alternative splicing isoform of
AMPA receptor subunits lacking both the flip/flop exons. In
hippocampal and retinal neurons in culture, the transcript encoding
this isoform contains a premature stop codon and gives rise to
truncated subunits lacking the flip/flop cassette, the fourth
transmembrane domain and the intracellular C-terminal domain.
We investigated the ability of these subunits to associate with full-
length subunits and form functional receptors, and analyzed the
cellular localization of AMPA receptors containing truncated
subunits. We also explored the hypothesis that AMPA receptors
containing truncated subunits may have a neuroprotective role in
excitotoxic conditions.
Results
Identification of splice variants of AMPA receptor subunits in
neuronal cultures
Total RNA isolated from rat hippocampal cultures 14 days in
vitro (DIV), and from chick retinal cultures 5 DIV, was amplified
by RT–PCR using primers for the AMPA receptor subunits
(GluR1–4), designed to span the segment encoding the flip/flop
region and part of the fourth transmembrane domain. Besides the
PCR products of predicted length (666 bp for GluR1, 486 bp for
GluR2, 496 bp for GluR3 and 622 bp for GluR4), lower molecular
weight products for GluR1–3 (551 bp for GluR1, 371 bp for
GluR2, and 381 bp for GluR3) were observed in hippocampal
cultures (Fig. 1A shows the amplification products for GluR1) and
for GluR4 (507 bp) in retinal cultures (Fig. 1B). The lower
molecular weight products were originally detected among
amplification products obtained using total cDNA (e.g., Fig. 1B),
but were more evident in the amplification products obtained after
cDNA digestion with RsaI, which digests the abundant cDNA
molecules containing the flip/flop region (e.g. Fig. 1A). Theseamplification products were isolated, subcloned and sequenced.
Sequence analysis showed that the lower molecular weight
transcripts correspond to AMPA receptor subunits lacking both
the flip and flop exons (Fig. 1C). Deletion of the flip/flop exons
introduces a premature stop codon and results in truncated
translation products, which lack the flip/flop region, the fourth
transmembrane domain and the C-terminus of the receptor subunits
(GluRΔi/o; Fig. 1D).
Functional characteristics of truncated AMPA receptor subunits
In order to determine whether this new splice isoform of AMPA
receptor subunits is capable of forming heteromeric receptors with
full-length AMPA receptor subunits, we tested for their biochem-
ical association when overexpressed in COS7 cells, using co-
immunoprecipitation assays. Using COS7 cells transfected with
GluR1 and GFP-GluR1Δi/o or GluR1 and GluR1Δi/o, we found
that truncated AMPA receptor subunits can co-immunoprecipitate
with full-length AMPA receptor subunits (Fig. 2A, middle panel)
and vice-versa (Fig. 2A, right panel). To understand whether the
truncated subunits form functional receptors, alone or in co-
expression with full-length subunits, we evaluated currents
generated by AMPA receptors containing the truncated subunits
(Fig. 2B). Whole-cell currents were measured in HEK 293 cells
transfected with a plasmid encoding the truncated form of GluR1
(GluR1Δi/o), and no currents could be detected in any of the cells
recorded (n=14, data not shown), so we concluded that homomeric
receptors of the truncated AMPA receptor subunits are not
functional (Fig. 2B). However, co-expression of truncated AMPA
receptor subunits with full-length constructs produced whole-cell
currents with lower amplitude than those observed when full-
length receptors were expressed, therefore exerting a dominant-
negative effect (Fig. 2B). We observed the same decrease in the
amplitude of whole-cell currents produced by GluR2- and GluR3-
containing receptors when co-expressed with GluR1Δi/o (data not
shown). In order to test whether the detected currents in cells co-
transfected with GluR1Δi/o and the full-length subunits were due
to the response of heteromeric receptors rather than to homomeric
full length receptors, we electrophysiologically tagged GluR1Δi/o
by replacing the glutamine residue (Q) at the pore forming region
of the receptor for an arginine (R). This replacement occurs
naturally by RNA editing in GluR2, and changes the rectification
characteristics of the currents (Verdoorn et al., 1991). The currents
recorded in cells co-transfected with GluR1Δi/o (R) and GluR1
had the same rectification index as the currents recorded in cells
transfected with GluR1 but presented a significant lower am-
plitude, indicating that the observed currents are generated by a
population of homomeric GluR1 receptors and that heteromeric
receptors containing the truncated AMPA receptor subunits are not
functional (Fig. 2C).
To understand how the truncated forms of AMPA receptor
subunits exert their dominant negative effect, we tested their
capacity to bind AMPA, and whether in heteromeric complexes
they interfere with the capacity of full-length AMPA receptor
subunits to bind AMPA (Fig. 3). Binding studies with [3H]AMPA
in extracts from HEK 293 cells transfected with the truncated form
of GluR1 (GluR1Δi/o) showed that GluR1Δi/o subunits do not
form binding sites for AMPA. However, when the truncated form
was co-transfected with full-length GluR1, the Bmax was not
affected, indicating the capacity of heteromeric receptors to bind
the ligand.
Fig. 1. Identification of splice variants of AMPA receptor subunits in rat hippocampal and chicken retina cultures. (A) RT–PCR products of AMPA receptor
subunit GluR1, amplified from hippocampal cultures, 14 DIV. Amplification was performed using primers that span the flip/flop region and part of TM4. In the
upper panel, the cDNAmolecules containing the flip/flop exons were partially digested with RsaI previous to amplification in order to facilitate the amplification
of the variant lacking the flip/flop exons (GluRΔi/o). (B) RT–PCR amplification of GluR4 subunit from chick retinal cultures, 5 DIV, using primers that span the
flip/flop region and part of TM4. (C) Comparison of the amplified nucleotide sequences encoding full-length and truncated isoforms of AMPA receptor GluR1,
and of the corresponding translation products. The 5 amino acid sequence originated by the frameshift, before the stop codon, is indicated. Corresponding
sequences for the other AMPA receptor subunits are: KRPVPSV (GluR2), TRPVL (GluR3) and TRRVP (GluR4). (D) Schematic representation of truncated
isoforms of AMPA receptor subunit, lacking the flip/flop cassette, the fourth transmembrane domain and the C-terminus (box).
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Because the C-terminal region of AMPA receptor subunits
contains multiple sites of interaction with cytosolic proteins
involved in AMPA receptor trafficking, we studied the cell surface
and subcellular localization of AMPA receptor containing
truncated subunits. The observation that the currents recorded
from cells co-transfected with full-length and truncated subunits
are due to the activity of receptors that do not incorporate truncated
subunits, and that mixed receptors do not produce currents, led to
the hypothesis that incorporation of truncated subunits in receptor
complexes may result in intracellular sequestration of full-length
subunits. In order to investigate the trafficking of truncated AMPA
receptor subunits to the cell surface, we transfected HEK 293 cells
with full-length GluR1, or truncated GluR1, tagged with GFP at
the N-terminus (GFP-GluR1Δi/o), and COS7 cells with GluR1 and
GluR1Δi/o. Cell surface proteins were biotinylated, and purified by
affinity chromatography. Western blot analysis of the purified
fraction revealed that truncated GluR1 subunits do reach the cell
surface, by themselves and when co-transfected with GluR1, to a
similar extent as full-length GluR1 (Figs. 4A, B). These results aresimilar for both constructs, with or without GFP, and do not
support the hypothesis that the truncated subunits prevent the full-
length subunits from reaching the plasma membrane. As a
complementary approach to the biotinylation experiments, we
transfected COS7 cells with GluR1 or GluR1Δi/o and labeled them
in vivo with an anti-GluR1 N-terminal antibody, before fixation, to
visualize superficial receptors. The results are in agreement with the
previous observations, showing superficial expression of truncated
GluR1 (Fig. 4C). We also observed cell surface expression of
truncated AMPA receptor isoforms in cultured hippocampal
neurons, by transfecting 14 DIV cultures with full-length and
truncated subunits, GFP-tagged, and immunolabeling with an anti-
GFP antibody in vivo (Fig. 4D). It is important to notice that
although both GFP-GluR1 and GFP-GluR1Δi/o reach the neuronal
surface, the full-length GluR1 shows a punctuate distribution
throughout the dendrites, whereas GluR1Δi/o shows a diffuse
distribution in the dendrites (Fig. 4E). To investigate the subcellular
localization of AMPA receptors containing the truncated GluR1
subunits, we transiently transfected hippocampal neurons (14 DIV)
with full-length or truncated GluR1, tagged with GFP at the N-
terminus. These cultures were labeled for PSD 95, a synaptic
marker, and were imaged by fluorescence microscopy (Fig. 4E). The
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Fig. 3. Saturation binding curve of [3H]AMPA in membranes of HEK 293
cells expressing GluR1, GluR1+GluR1Δi/o (1:1) or GluR1Δi/o. HEK 293
cells were transfected and cell membranes were isolated. The curves
represent specific binding of [3H]AMPA, calculated as the difference
between the total binding and the nondisplaceable binding, as a function of
the concentration of free [3H]AMPA. There is no statistically significant
difference between the curves for cells expressing GluR1 and expressing
GluR1+GluR1Δi/o (p=0.18). BMAX and KD were determined using non-
linear regression followed by one site binding hyperbola equation. Data are
relative to three independent experiments done in triplicate. The recombi-
nant protein levels were found to be similar in all conditions by Western blot
analysis (not shown).
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punctate labelingwhich co-localizes with PSD-95, whereas truncated
GluR1 showed little co-localization with the synaptic marker
(Fig. 4E).
Truncated GluR1 protects against excitotoxic insults
The electrophysiology data showed that truncated forms of
AMPA receptor subunits produce a dominant-negative effect when
incorporated in AMPA receptors (Fig. 2B). This observation led us
to investigate whether these truncated subunits could have aFig. 2. GluR1Δi/o acts as a dominant negative when co-expressed with full-length G
COS7 cells were transfected with GluR1, GluR1Δi/o or GFP-GluR1Δi/o and im
transfected cells) or with an anti-GluR1 C-terminus antibody (for GluR1Δi/o or
transfected with GluR1 and GluR1Δi/o were used for immunoprecipitation with
transfected with GFP-GluR1Δi/o and GluR1 and an anti-GFP antibody was used in
Western blot analysis, as indicated, and a bead control was performed for all cell ex
measured at −60 mV. Cells expressing growing amounts of GluR1Δi/o and a consta
were transfected with GluR1 or GluR1+GluR1Δi/o. Glutamate-evoked currents
GluR1+GluR1Δi/o transfected cells was expressed as a fraction of the responses ob
as average±S.E.M. for n=16 (GluR1 transfection), n=13 (GluR1+GluR1Δi/o
statistical analysis was performed using one-way ANOVA followed by Bonferro
heteromeric GluR1-GluR1Δi/o receptors. Whole-cell currents of HEK 293 cells tra
mutation, replacing a glutamine residue (Q) at the pore-forming region of the recep
the rectification characteristics of the currents. The fact that GluR1+GluR1Δi/oR do
at negative potentials are generated by a population of homomeric GluR1 recepto
subunits are not functional.protective effect against excitotoxic insults. To test this hypothesis
we incubated 6 DIV hippocampal cultures transfected at 5 DIV with
GFP, with GFP-GluR1, with GFP-GluR1Δi/o, or co-transfected with
GFP-GluR1 and GFP-GluR1Δi/o, with 125 μM of glutamate for
20 minutes. Four independent hippocampal cultures were analyzed,
and, for each culture, 120 to 150 transfected cells were scored for
each condition. Apoptotic death of transfected cells was assessed by
analyzing nuclear morphology, 14 hours after the excitotoxic insult,
using Hoechst 33342 (Fig. 5B). Apoptotic morphology is typically
characterized by chromatin condensation and loss of neurites.
Among GFP-transfected cells, approximately 16%±7% were found
to be apoptotic in glutamate-treated cultures. This was taken as the
control condition (100% cell death) and cell death in other con-
ditions was normalized to cell death among GFP-transfected cells
(Fig. 5A). Transfection of hippocampal neurons with GluR1Δi/o
alone did not significantly alter apoptotic cell death in response to
glutamate (13%±4, among transfected cells). However, among the
neurons co-transfected with GFP-GluR1 and GFP-GluR1Δi/o, there
was a significantly smaller proportion of apoptotic cells (24%±13,
among transfected cells) than among neurons transfected with GFP-
GluR1 only (41%±14, among transfected cells; Pb0.05; Fig. 5A)
in the glutamate-treated preparations. These results suggest that
the truncated isoform of GluR1 confers protection against the
excitotoxic insult when it hetero-oligomerizes with full-length
GluR1.
Expression of the transcripts for truncated AMPA receptor subunits
in conditions of excitotoxicity and in epileptic rats
Because our results support the hypothesis that AMPA
receptors containing truncated subunits may have a neuroprotective
role in excitotoxic conditions, we investigated the circumstances
under which the expression of truncated forms of AMPA receptor
subunits would be increased. We amplified the transcripts for
AMPA receptor subunits from total RNA isolated from hippo-
campal cultures 14 DIV, 4 hours after these cells were incubated
with 150 μM of glutamate for 20 min (an insult that causes
excitotoxic neuronal damage—not shown). We consistently
detected the expression of the transcript for the truncated form of
AMPA receptor subunit GluR1 (Fig. 5C) by PCR from non-
digested cDNA samples obtained from RNA isolated from
glutamate-treated hippocampal neurons (the transcript encoding
truncated GluR1 was clearly detected even without previous
digestion with RsaI of the full-length cDNA molecules). TakingluR1. (A) Co-immunoprecipitation of GluR1Δi/o and GluR1. Left column:
munoprecipitation was performed with an anti-GFP antibody (for GluR1
GFP-GluR1Δi/o transfected cells). Middle column: Extracts from cells co-
an anti-GluR1 C-terminus antibody. Right column: COS7 cells were co-
the immunoprecipitation assay. Immunoprecipitated proteins were subject to
tracts (right lane of every panel). (B) Whole-cell currents of HEK 293 cells
nt amount of GluR1 were stimulated with 1 mM glutamate. Sister HEK cells
were measured in parallel. The amplitude of glutamate-induced currents in
served in GluR1 transfections, which were taken as 100%. Data are presented
(1:1) co-transfection), n=6 (GluR1+GluR1Δi/o (1:3) co-transfection);
ni's Multiple Comparison Test: ⁎pb0.05, ⁎⁎pb0.01. (C) Non-functional
nsfected with GluR1, GluR1+GluR1R and GluR1+GluR1Δi/oR. The Q/R
tor for an arginine (R) (occurs naturally by RNA editing in GluR2), changes
es not have currents at positive potentials indicates that the observed currents
rs and that heteromeric receptors containing the truncated AMPA receptor
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truncated forms of AMPA receptor subunits in the brain of
epileptic rats, as epilepsy is characterized by increased neuronal
activity (Fujikawa, 2005). We isolated total RNA from several
brain regions of kainate-induced epileptic rats 24 h after injection
of kainate. AMPA receptor subunits were amplified by RT–PCR
and lower molecular weight PCR products were isolated,
subcloned and sequenced. We detected the expression of the
transcripts for truncated GluR3 in the cortex and hippocampus of
epileptic rats by PCR from undigested cDNA samples, whereas
these transcripts were not detected in the brain of control animals
(Fig. 5D).Fig. 4. Cell surface expression and subcellular localization of AMPA receptors con
from HEK 293 cells, transfected with GluR1 and GFP-GluR1Δi/o, and analyzed by
purified from COS7 cells expressing both GluR1 and GluR1Δi/o, and probed wi
GluR1 and GluR1Δi/o with anti-GluR1 N-terminal antibody, and total staining of
Immunofluorescence staining in vivo with anti-GFP antibody of cell surface recepto
and GFP-GluR1Δi/o. (E) Double immunostaining of GFP and PSD 95 in permeab
GFP-GluR1Δi/o. Merged images of labeling with anti-GFP and anti-PSD 95 antibo
isoform, with the synaptic marker. The lower panel shows high-magnification imaDiscussion
The alternative splicing of AMPA receptor subunits at the flip/
flop exons is well known and the flip and flop isoforms are well
characterized, but the mechanism of regulation that chooses the
splice sites is still intriguing. We identified, by RT–PCR, a new
isoform of AMPA receptor subunits in hippocampal (Fig. 1A) and
retinal cultures (Fig. 1B), which lacks the flip/flop exons. The
removal of the flip/flop cassette alters the reading frame and gives
rise to a premature stop codon (Fig. 1C). These transcripts encode
truncated subunits lacking the fourth transmembrane domain and
the intracellular C-terminus (Fig. 1D), weighting about 16 kDataining truncated GluR1. (A) Biotinylated cell surface proteins were purified
Western blot with anti-GFP antibody. Additionally, cell surface proteins were
th an anti-GluR1 N-terminal antibody (B). (C) Surface staining (in vivo) of
GluR1 with anti-GluR1 C-terminal antibody in transfected COS7 cells. (D)
rs in hippocampal neurons (18 DIV), transfected at 14 DIV with GFP-GluR1
ilized hippocampal neurons transfected at 14 DIV with GFP-GluR1 and/or
dies show co-localization of the full-length subunit, but not of the truncated
ges of the boxed regions of the images in the upper panel.
Fig. 4 (continued ).
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for truncated forms of the kainate receptor subunit GluR6 (Barbon
et al., 2001), and Ravindranathan and colleagues identified three
isoforms of GluR4 in chick that can be alternatively spliced and, if
expressed, may encode receptors with a shorter C-terminal domain
than GluR4 (Ravindranathan et al., 1997). However, the functional
characteristics of these splice isoforms were not explored.
The levels of expression of the transcripts encoding the truncated
AMPA receptor splice isoforms that we detected are low, and we
could not detect truncated GluR1 protein in cultured neurons or in
brain extracts, using an antibody against the N-terminus of the
protein. However, we do not have evidences for nonsense-mediated
mRNA decay (NMD) of the transcripts that lack the flip/flop exons
because incubation of hippocampal neurons in culture with emetine,
a protein synthesis blocker, did not increase the expression of these
transcripts (data not shown). NMD ensures rapid degradation of
aberrant mRNAs through a mechanism that depends on protein
synthesis (Conti and Izaurralde, 2005). If this mechanism was at
work for the transcripts lacking the flip/flop exons, their levels
should increase upon blockade of translation.
Truncated AMPA receptor subunits heteroligomerize with full-
length subunits (Fig. 2A). However, truncated subunits cannot
form homomeric or heteromeric functional receptors (Figs. 2B, C).
Furthermore, truncated AMPA receptor subunits do not bind
AMPA (Fig. 3). The ligand-binding domain of AMPA receptor is
split into S1 and S2 subdomains by transmembrane segments.
When the ligand binds to the receptor, conformational changes are
transduced to the transmembrane segments to open the channel's
gate (Greger et al., 2006). The truncated subunits do not have an
intact S2 region, which probably impairs the exposure of the amino
acids responsible for the establishment of interactions between the
receptor and the ligand. This could explain why heteromeric
receptors are non-functional but truncated subunits do not interferewith ligand binding of full-length subunits. We cannot exclude that
the oligomerization between truncated and full-length subunits can
only lead to the formation of dimers through the N-terminal
domains (Leuschner and Hoch, 1999; Ayalon and Stern-Bach,
2001; Wells et al., 2001). However, the fact that truncated subunits
can oligomerize with full-length AMPA receptor subunits in
nonfunctional receptors, sequestrating these subunits and conse-
quently decreasing the available functional AMPA receptors, can
explain the dominant negative effect of truncated AMPA receptor
subunits.
Many studies focus on mechanisms of AMPA receptor
trafficking mediated by protein partners (reviewed by Bredt and
Nicoll, 2003), and most AMPA receptor-interacting proteins
identified so far bind to the C-terminal tails of AMPA receptor
subunits (Luscher et al., 2000; Bredt and Nicoll, 2003). Surprisingly,
we observed using different approaches that AMPA receptors
containing truncated subunits reach the cell surface (Fig. 4).
However, although the superficial labeling in hippocampal neurons
transfected with full-length GluR1 was punctated throughout the
dendrites, neurons transfected with GluR1Δi/o had a more diffuse
labeling that was mostly accumulated in the cell body (Fig. 4D).
Although the C-terminus has several sites of interaction with
proteins involved in the receptor traffic to the cell membrane (Bredt
and Nicoll, 2003), it does not seem to be essential for this traffic to
occur. The C-terminus fragment of GluR1 AMPA receptor subunit
proximal to the membrane has been related to the dendritic sorting in
neurons (Ruberti and Dotti, 2000). Therefore, to investigate the
localization of AMPA receptors containing truncated GluR1
subunits, we double-immunolabeled hippocampal neurons trans-
fected with GFP-GluR1 or GFP-GluR1Δi/o, with anti-GFP and anti-
PSD 95 (Fig. 4E). Merged images show that only AMPA receptors
containing full-length GluR1 subunits reach the synapses, whereas
AMPA receptors containing truncated GluR1 subunits fail to traffic
330 A.R. Gomes et al. / Mol. Cell. Neurosci. 37 (2008) 323–334to the synapse. Co-transfection with GluR1 does not rescue
truncated receptors to reach the synapse. These results indicate that
C-terminus has a crucial role on the synaptic targeting of GluR1,
probably by interacting with intracellular proteins, like Protein 4.1,
that in association with SAP 97 has been suggested to regulate
synaptic localization of GluR1 (Rumbaugh et al., 2003).Fig. 5. Truncated isoforms of AMPA receptor subunits may be associated with neu
(A) Hippocampal neurons transfected at 5 DIV with GFP-GluR1 and GFP-Gl
immunolabeled with anti-GFP antibody, 14 h later. The viability of GFP-expressin
Hoechst 33342. Data are presented as average±S.E.M. of four experiments, perfo
death observed in hippocampal neurons transfected with GFP alone (taken as 10
Bonferroni's Multiple Comparison Test: ⁎⁎pb0.01 for GFP-GluR1 versus GFP, wh
GluR1+GFP-GluR1Δi/o versus GFP-GluR1, in control conditions, and for GFP-G
(B) Nuclear morphology of hippocampal neurons 7 DIV transfected with GFP-Glu
anti-GFP, in the presence or in the absence of the glutamate stimulus (white arrows,
in hippocampal cultures stimulated at 14 DIV with glutamate (150 μM) for 20 m
digested cDNA samples and the amplification products were analyzed in an agar
GluR3 in the cortex and in the hippocampus of epileptic rats, sacrificed 24 h after
RNA isolated from the hippocampus and the cortex of epileptic rats, without digesti
from the striatum, olfactory bulb, cerebellum, and brainstem, the samples wer
amplification. The bottom panel shows the RT–PCR products obtained using RNThe dominant-negative functional effect that we observed for
the truncated AMPA receptor subunits led us to speculate about a
possible neuroprotective role of these receptors in excitotoxic
situations. Their insertion at the plasma membrane, and the
formation of non-functional heteromeric complexes with full-
length AMPA receptor subunits, diminishing the amount of full-ronal protection against excitotoxic stimuli and increased neuronal activity.
uR1Δi/o were incubated at 6 DIV with glutamate (125 μM), fixed and
g cells was evaluated by fluorescence microscopy using the fluorescent dye
rmed in independent preparations, and are expressed as a percentage of cell
0%). Statistical analysis was performed by one-way ANOVA followed by
en stimulated with glutamate; ⁎pb0.05 for GFP-GluR1 versus GFP and GFP-
luR1+GFP-GluR1Δi/o versus GFP-GluR1, when stimulated with glutamate.
R1 and co-transfected with GFP-GluR1 and GFP-GluR1Δi/o, labeled with
transfected cells). (C) Expression of truncated AMPA receptor subunit GluR1
in. Total RNA was extracted 4 h later, RT–PCR was performed using non-
ose gel, isolated and sequenced. (D) Expression of AMPA receptor subunit
kainate injection. Products were amplified by PCR of cDNA obtained from
on with RsaI to eliminate full-length transcripts. In the case of cDNA samples
e digested with RsaI to eliminate the full-length transcripts before PCR
A isolated from control rats.
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balance the availability of functional AMPA receptors, which
overactivation is associated with apoptotic cell death mediated by
an excessive calcium influx (Kwak and Weiss, 2006). To test the
possible protective role of truncated AMPA receptor subunits
against apoptotic cell death induced by an excitotoxic stimulus, we
incubated hippocampal neurons transfected with GluR1, or co-
transfected with GluR1 and GluR1Δi/o, with toxic concentrations
of glutamate (Figs. 5A, B). Co-transfection with truncated GluR1
resulted in a significant reduction of apoptotic cell death (Fig. 5A),
which was probably due to a reduction in the number of functional
AMPA receptors in the plasma membrane, and which supports the
hypothesis that AMPA receptors containing truncated subunits may
have a neuroprotective role against excessive release of glutamate.
This raised the hypothesis that the expression of truncated AMPA
receptor subunits could be increased in excitotoxicity conditions
and in diseases such as epilepsy, as a result of an intrinsic neuro-
protective response that minimizes the damage resulting from
increased neuronal activity. We consistently observed expression of
the GluR1 transcript lacking the flip/flop exons in hippocampal
cultures stimulated with toxic concentrations of glutamate (Fig. 5C)
and expression of the GluR3Δi/o transcript in the hippocampus and
cortex of epileptic rats, sacrificed 24 hours after the kainate insult
(Fig. 5D). Interestingly, recent studies have found autoantibodies
against GluR3 in the sera and cerebrospinal fluid of patients with
severe forms of epilepsy (Mantegazza et al., 2002; Ganor et al.,
2005), and these autoantibodies display glutamatergic agonist
activity, which suggest that, at high concentrations and after a
seizure-induced breakdown of the blood–brain barrier, excessive
AMPA receptor activation by the anti-GluR3 autoantibodies might
kill neurons by excitotoxicity (Cohen-Kashi Malina et al., 2006).
The expression of truncated GluR3 would counteract this effect and
constitute an intrinsic protective mechanism.
The mechanism of splicing that might be involved in the
skipping of the flip/flop exon in AMPA receptor subunit transcripts
must be studied in detail. Manipulation of the expression of these
alternative splice isoforms could regulate the availability of
functional AMPA receptors in situations of excessive release of
glutamate, thereby preventing further losses in these situations.
Experimental methods
Materials
Dulbecco's Modified Eagle's Medium was purchased from Sigma
(Madrid, Spain). Neurobasal medium, the B27 supplement and the
OptiMEM I medium were purchased from Gibco Invitrogen (Paisley
UK). Plasmid maxi and midiprep system were purchased from Qiagen
(Germantown, USA). Trypsin was from Invitrogen–Gibco Life Technolo-
gies (Paisley, UK) and fetal calf serum was from Biowhittaker (Walkers-
ville, MD, USA). Lipofectamine was purchased from Invitrogen
(Barcelona, Spain). Anti-GFP monoclonal antibody, complete Mini
protease inhibitor cocktail, high pure PCR product purification kit and
microporous polyvinylidene difluoride (PVDF) membranes were purchased
from Roche Diagnostics GmbH (Basel, Switzerland). First Strand cDNA
Synthesis Kit for RT–PCR was purchase from Roche Applied Science
(Indianapolis, IN). Quick Change Mutagenesis Kit was purchased from
Stratagene Cloning Systems (Cambridge, UK). Anti-GFP polyclonal
antibody was purchased from MBL International Corporation (Woburn,
USA), anti-PSD 95 antibody was from Affinity BioReagents (Golden, CO)
and anti-GluR1 polyclonal antibody was from Tocris Bioscience (Missouri,
USA). The sheep anti-GluR1 N-terminal antibody was a kind gift from
Andrew Irving (University of Dundee, Scotland). Anti-actin antibody waspurchased from Roche Molecular Biochemicals (Indianapolis, IN). The
alkaline phosphatase-conjugated anti-rabbit and anti-mouse secondary
antibodies, and the ECF immunodetection substrate, were obtained from
Amersham Biosciences (Uppsala, Sweden). Secondary fluorescent anti-
bodies anti-rabbit Alexa 488 and Alexa 594, anti-sheep Alexa 488 and anti-
mouse Texas Red were purchased from Molecular Probes (Leiden, The
Netherlands). EZ-link Sulfo-NHS-SS-biotin and UltraLink Plus Immobi-
lized Neutravidin Gel were purchased from Pierce (Rockford, IL, USA).
pGEM-T Easy Vector was purchase from Promega (Madison, USA) and
pEGFP-C1 vector from Clontech (Mountain View, USA). [3H]AMPA
(43.5 Ci/mmol) was obtained from Perkin-Elmer Life Sciences (Boston,
MA). All the other reagents were obtained from Sigma (St. Louis, MO,
USA) or from Merck (Darmstadt, Germany).
Constructs and primers
The GluR1Δi/o (construct coding for GluR1 lacking the flip and flop
exons, Figs. 1C, D) was prepared by fusion PCR, using the GluR1 construct
as a template and the PCR product (551 bp) obtained from the amplification
of GluR1Δi/o from rat cerebellum cDNA with primers 5′ GAA CCA TCC
GTG TTT GTT CG 3′ (Forward) and 5′ TTC CTG TCT GCT CCA GTT
AC 3′ (Reverse).
Plasmids encoding GFP-tagged GluR1 and GFP-tagged GluR1Δi/o
were prepared by inserting EGFP coding region at the N-terminus of GluR1
and GluR1Δi/o, after the signal peptide. With the Quick Change
Mutagenesis Kit (Stratagene Cloning Systems), an XbaI restriction site
was created in the GluR1 and GluR1Δi/o constructs, using primers 5′ GGT
TGT GGG TGC CAATTT TCC TCT AGA AAT ATC CAG ATA GGG G
3′ and 5′ CCC CTATCT GGATAT TTC TAG AGG AAA ATT GGC ACC
CAC AAC C 3′. EGFP cDNA was extracted from the pEGFP-C1 plasmid
(Clontech) with XbaI and NheI enzymes and inserted at the XbaI restriction
site.
GluR1(R) and GluR1Δi/o(R) were prepared with the Quick Change
Mutagenesis Kit, using theGluR1 andGluR1Δi/o constructs as templates and
primers 5′GGCCTTCATGCGGCAAGGATGTGATATCTCCCCCAG
GTCC3′ and 5′GGACCTGGGGGAGATATCACATCCTTGCCGCAT
GAA GGC C 3′.
Primers used for PCR amplification of the different rat AMPA receptor
subunits were as follows: 5′ GAA CCATCC GTG TTT GTT CG 3′ (GluR1
forward); 5′ TTC CTG TCTGCT CCAGTTAC 3′ (GluR1 reverse); 5′GAA
GCC TTG TGACACCATGA 3′ (GluR2 forward); 5′AGCCTTGCC TTG
CTC CTCAT 3′ (GluR2 reverse); 5′ CAAAGGCTATGG TGTGGCAA 3′
(GluR3 forward); 5′ ACA CCA GGG AGA GTG AAA TC 3′ (GluR3
reverse); 5′TGGAGGGCGTGGCTCGTGTC 3′ (GluR4 forward); 5′TTG
GGG CAG TCA GGG GTA AG 3′ (GluR4 reverse). Chick GluR4 PCR
primers were 5′ AAA TCA GCA GAG CCG TCA G 3′ (forward); 5′ TTT
ATG GTA GGT CCG ATG CA 3′ (reverse).Isolation of total RNA
Total RNA was isolated from rat brain or hippocampal or retinal cell
cultures using the Trizol Reagent (Invitrogen). Briefly, tissue was
homogenized in Trizol. After adding chloroform, the RNA was isolated
in the aqueous phase. The RNA was precipitated with isopropanol, and the
RNA pellet was washed with 75% ethanol and redissolved in diethylpyr-
ocarbonate (DEPC)-treated water. The total amount of RNAwas quantified
by optical density measurements at 260 nm, and the purity was evaluated
by measuring the ratio of OD at 260 and 280 nm.RT–PCR and PCR experiments
Using the First Strand cDNA Synthesis Kit (Roche Applied Science),
1 μg RNA was reverse transcribed into single-stranded cDNA, using avian
microblastosis virus reverse transcriptase (AMV) and an Oligo-p(dT)15
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different subunits. Before amplification, half of the cDNA obtained was
digested with RsaI (New England Biolabs) for 1 h, at 37 °C, in order to
digest the cDNA molecules containing the flip or flop regions. Polymerase
chain reactions of digested and non-digested samples were performed in a
100-μl reaction volume containing at least 1 μg of template cDNA, 10 mM
of each deoxynucleotide, 20 μM of each primer, 0.02 units/μl Taq
polymerase and the appropriate buffer, for 35 cycles of 30s at 94 °C, 30 s at
57 °C (for GluR1, 2 and 3 subunits) or at 60 °C (for GluR4) and 1 min at
72 °C. PCR products were subjected to electrophoresis in a 1.5% agarose
gel and stained with ethidium bromide. Lower weight bands were isolated
with high pure PCR product purification kit (Roche), cloned in pGEM-T
Easy Vector (Promega) and sequenced.
Cell cultures
Human embryonic kidney (HEK 293) and kidney fibroblast (COS7)
cell lines were grown in Dulbecco's modified Eagle's medium, supple-
mented with 10% fetal calf serum and kept at 37 °C in a humidified
incubator.
Primary cultures of rat hippocampal neurons were prepared from the
hippocampus of E18–E19 Wistar rat embryos. Hippocampi were dissected
and dissociated with trypsin (0.5 mg/ml, 15 min, 37 °C) and deoxyr-
ibonuclease I (0.20 mg/ml), in Ca2+ and Mg2+-free Hank's balanced salt
solution (HBSS; 137 mM NaCl, 5.36 mM KCl, 0.44 mM KH2PO4,
0.34 mM Na2HPO4 · 2H2O, 4.16 mM NaHCO3, 5 mM glucose,
supplemented with 0.001% phenol red, 1 mM sodium pyruvate and
10 mM HEPES, pH 7.4). The hippocampi were then washed in HBSS
supplemented with 10% FCS in order to stop trypsin activity and
mechanically dissociated in HBSS. Hippocampal cultures were maintained
in Neurobasal medium, supplemented with B27 supplement, glutamate
(25 μM), glutamine (0.5 mM) and gentamicin (0.12 mg/ml). The cells were
kept at 37 °C in a humidified incubator of 5% CO2/95% air. Cultures were
used after 7 or 15 days in vitro (DIV).
Primary cultures of chick retina amacrine-like neurons were prepared as
previously described (Duarte et al., 1996; Gomes et al., 2004). Briefly, the
retinas from 8-day-old chick embryos (White Leghorn) were dissected and
digested with 0.1% trypsin, in Ca2+- and Mg2+-free Hank's balanced salt
solution for 15 min at 37 °C. The cells were cultured on poly-D-lysine tissue
culture dishes in basal medium of Eagle (BME), buffered with 25 mM
HEPES and 10 mM NaHCO3, pH 7.4, and supplemented with 5% heat-
inactivated fetal calf serum, penicillin (100 U/ml), and streptomycin
(100 μg/ml). The cells were maintained at 37 °C in a humidified incubator
with 95% air and 5% CO2, and used after 5 DIV.Transfection experiments
HEK 293 cells were transiently transfected (Carvalho et al., 1999) by
calcium phosphate precipitation with 2 μg of DNA per well in a six-well
plate. Cells were washed twice with fresh medium, 8 h after the addition of
DNA/calcium phosphate precipitate. Experimental treatments started 48 h
after transfection. COS7 cells were transfected using lipofectamine reagent.
Each well of a six-well plate was loaded with 250 μl of Opti-MEM solution
containing 2 μg of DNA and 12.5 μl of lipofectamine reagent, and
incubated for 5 h. The cells were used 48 h after transfection.
Hippocampal neurons were transiently transfected at 5 DIV or 14 DIV
using a calcium phosphate co-precipitation protocol (Jiang et al., 2004).
Cells were cultured at a density of 45×103 cells/cm2. The DNA/calcium
phosphate precipitate was prepared by mixing one volume of DNA (diluted
in 1× TE pH 7.3 in 2.5 M CaCl2 in 10 mM HEPES) with an equal volume
of 2× HeBS solution (274 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4,
15 mM D-glucose, 42 mM HEPES, pH 7.2). For each well of a 24- or 12-
well plate, the amount of DNA used was 2 μg or 4 μg, respectively. The
precipitate was let to form for 30 min at room temperature, vortexing every
5 min. While the precipitate was developing, coverslips were transferred to
new wells containing 200 μl of conditioned medium and kynurenic acid10 mM. After the addition of the precipitates, cells were returned to the
incubator for another 3 h. Each coverslip was then transferred to a fresh
well containing 1 ml of 10% CO2 equilibrated (acidic) glutamate-free
Neurobasal Medium (MNB), containing 2 mM kynurenic acid, and
returned to the incubator for another 15 min. Neurons were then returned
to the original wells containing the conditioned medium.Biotinylation and purification of plasma membrane-associated proteins
Cells were washed twice with phosphate-buffered saline (PBS) with
calcium and magnesium (PBS/Ca2+/Mg2+: 137 mM NaCl; 2.7 mM KCl;
1.8 mM KH2PO4; 10 mM Na2HPO4; plus 0.5 mM MgCl2; 1 mM CaCl2;
pH 7.4), and then incubated with 1 mg/ml NHS-SS-Biotin for 30 min at
4 °C under mild shaking. Cells were then washed twice with PBS/Ca2+/Mg2+
supplemented with glycine (100 mM) and incubated in the same solution for
45 min. Cells were lysed with RIPA buffer supplemented with protease and
phosphatase inhibitors, scraped off the plates, sonicated for 30 s on ice and
centrifuged at 14,000 rpm for 10 min at 4 °C. The supernatant fluids were
transferred to clean tubes. NeutrAvidin beads (Pierce) were added to equal
amounts of supernatant fluid (2 μl/10 μg total protein) and incubated for 2 h
at 4 °C with mild shaking (orbital shaker). The beads were washed four times
with RIPA buffer by centrifugation (2500×g, 3 min). The samples were
eluted with sample buffer (100 mM Tris, 100 mM glycine, 4% SDS, 8%
β-mercaptoethanol, 8 M urea and 1.5 mM sodium orthovanadate) and
centrifuged into a tube collector with filter.SDS–PAGE and Immunoblotting
The extracts obtained were resolved by SDS–PAGE in 10%
polyacrylamide gels. This was followed by overnight electrotransfer to
PVDF membranes, at 40 V, complemented by 30 min at 200 V, at room
temperature. Membranes were then blocked for 1 h at room temperature, in
Tris-buffered saline (137 mM NaCl, 20 mM Tris–HCl, pH 7.6) containing
0.1% (v/v) Tween 20 (TBS-T) and 5% (w/v) low-fat milk, and probed for
1 h with the primary antibodies (anti-GFP 1:1000, anti-GluR1 C-terminal
1:500 and anti-GluR1 N-terminal 1:750) diluted in TBS-T containing 0.5%
low-fat milk at room temperature. Following five washes (5 min) in TBS-T,
the membranes were incubated for 1 h with the respective alkaline
phosphatase-conjugated secondary antibodies (anti-mouse and anti-rabbit
1:20000 and anti-sheep 1:10000). The membranes were then washed again
five times (5 min), incubated with chemifluorescence substrate (ECF) for
5 min, and scanned with the Storm 860 scanner (Amersham Biosciences).
Where indicated the membranes were stripped and reprobed with mouse
anti-actin antibody (1:10000).
Stimuli
For cell viability experiments, hippocampal neurons in culture (6 DIV)
were incubated with 125 μM glutamate in supplemented Neurobasal
medium, for 20 min at 37 °C, in a humidified incubator. After stimulation
with glutamate, the cells were further incubated with the original culture
medium, for 14 h at 37 °C. For mRNA isolation, hippocampal cells (14
DIV) were incubated with 150 μM glutamate in supplemented Neurobasal
medium, for 20 min at 37 °C, in a humidified incubator. After stimulation
with glutamate, the cells were further incubated with original culture
medium, for 2 to 4 h at 37 °C.Cell viability
Cell viability was measured after fixing the cells in 4% paraformalde-
hyde and 4% sucrose for 10 min at room temperature. Fixed cells were
washed with phosphate-buffered saline (PBS) and stained with the fluo-
rescent dye Hoechst 33342 (0.5 μg/ml). The coverslips were mounted
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microscope.
Immunostaining
Hippocampal cells were fixed in 4% paraformaldehyde and 4% sucrose
for 10 min at room temperature and then incubated with 0.2% gelatine in
PBS-T (PBS with 0.1% Tween) for 1 h, at room temperature. For double
labeling of neurons for receptors tagged with GFP and for PDS 95, the cells
were incubated with monoclonal antibodies anti-GFP (1:200) and anti-PSD
95 (1:200). After 1 h incubation, cells were washed with PBS-T with 0.1%
gelatine, for 5 min, and incubated with secondary antibodies anti-rabbit
Alexa 488 (1:500) and anti-mouse Texas-Red (1:1000) for 1 h. To detect
surface expression, transfected neurons were labeled in vivo with anti-GFP
antibody (1:200) and COS7 cells with anti-GluR1 N-terminal antibody
(1:200) for 20 min at 4 °C, washed two times with PBS and then fixed and
incubated with 0.2% gelatine in PBS-T for 1 h, at room temperature. After
washing with 0.1% gelatine PBS-T, cells were incubated with secondary
antibodies anti-rabbit Alexa 594 (1:200) and anti-sheep Alexa 488 (1:200),
respectively. The coverslips were mounted on glass slides and examined
under a Zeiss Axiovert 200 fluorescence microscope, coupled to an Axion
Cam HZM camera.
Co-immunoprecipitation assay
Co-precipitation experiments were preformed as previously described
by Ayalon and Stern-Bach (2001). Briefly, 24 to 48 h after transfection,
COS7 cells were washed with warm PBS, scraped, collected and
homogenized in ice-cold solubilization buffer (20 mM Tris–HCl, pH 8.0,
100 mM NaCl, 1% Triton X-100, 0.05% SDS) in the presence of a cocktail
of protease inhibitors (Complete mini). Clear supernatants were incubated
with protein A sepharose and anti-GluR1 C-terminus, anti-GluR1 N-
terminus or anti-GFP antibodies for 4 h at 4 °C with shaking. Beads were
then washed twice with 1 ml ice-cold solubilization buffer. Bound proteins
were released by 5 min boiling with SDS–PAGE loading buffer and
collected after a short centrifugation. Western blot analysis was performed
as described above.Electrophysiology
Glutamate-induced responses were recorded from HEK 293 cells 24 to
48 h after transfection, under the whole-cell configuration of the patch
clamp technique. The internal pipette solution was 120 mM CsMeSO,
10 mM EGTA, 0.5 mM CaCl2, 5 mM MgCl2, 15 mM CsCl, and 10 mM
HEPES, pH 7.3 and the external solution consisted of (in mM) NaCl 120,
KCl 2.5, CaCl2 1.8, MgCl2 2, glucose 10 and HEPES 10 (pH 7.3). Cells
were rapidly perfused as described previously (Rozas et al., 2003). Data
analysis was done with pCLAMP software (AXON Instruments).
Experiments were carried out at room temperature (22–25 °C).
Binding assays
HEK 293 cells were transfected as described above. After being washed
with PBS, cells were scraped and centrifuged at 14,000×g for 5 min at 4 °C.
The pellet was frozen at −20 °C for at least 2 h, and was resuspended in
water with protease inhibitors, at 4 °C. Cell membranes were obtained by
sedimentation of the lysate at 50,000×g for 15 min at 4 °C. The membrane
pellet was then resuspended in 50 mM Tris–HCl (pH 7.5), followed by
protein quantification with the BCA method.
The [3H]AMPA binding assays were performed with 500 μg of protein
in 50 mM Tris–HCl (pH 7.5) supplemented with 0.3 M KSCN, and
different concentrations of [3H]AMPA (1–300 nM), in the absence (total
binding) or presence of 1 mM glutamate (nondisplaceable binding).
Incubations were performed for 1 h at 4 °C and ligand binding was stoppedby filtration through pre-washed Whatman GF/C filters (Whatman,
Middlesex, UK). Filters were then washed rapidly three times, with ice-
cold 50 mM Tris–HCl, pH 7.4, supplemented by 0.1 M KSCN. The filters
were incubated in a scintillation cocktail containing 2,5-diphenyloxazol
(PPO) (5.84 g/l) and 1,4-bis (5-phenyl-2-oxazolyl) benzene (POPOP)
(133.6 mg/l), in a 4:1 mixture of toluol and triton X-100, for at least 8 h,
before measuring the radioactivity in a Packard 2000 Spectrometer
provided with dpm correction.Kainate treatment
Samples from epileptic rats were kindly provided by Ana Paula Silva
and João Malva (Center for Neuroscience and Cell Biology, University of
Coimbra, Portugal). Male 6-week-old Wistar rats (150–200 g) were injected
intraperitoneally with kainic acid (KA) (Sigma, St. Louis, MO, USA;
10 mg/kg body weight) in a maximum volume of 500 μl sterile 0.9% NaCl.
All the animals used in the present study achieved status epilepticus and
were killed 24 h after KA injection.
Statistical analysis
Results are presented as average±S.E.M. of the indicated number of
experiments, carried out in different preparations. Results were analyzed
using one-way ANOVA, followed by Bonferroni's Multiple Comparison
Test, or using the Student's t test.
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